Ascendis Pharma A/S Announces Third Quarter 2018 Financial Results and Business Update Conference Call on November 28
COPENHAGEN, Denmark, Nov. 14, 2018 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology […]